Gastroenterology News & Articles

1 Vitamin D Status and Per-oral Vitamin D Supplementation in Patients Suffering from Chronic Pancreatitis and Pancreatic Cancer Disease Anticancer Research, May 17, 2012    Clinical Article

2 Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level Journal of Gastroenterology, May 17, 2012    Clinical Article

3 Combination Therapy with Gemcitabine (GEM) and Erlotinib (E) in Exocrine Pancreatic Cancer under Special Reference to RASH and the Tumour Marker CA19-9 Anticancer Research, May 17, 2012    Clinical Article

4 The effects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea Alimentary Pharmacology and Therapeutics, May 17, 2012    Clinical Article

5 LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients Hepatology, May 17, 2012    Clinical Article

6 Cytokeratin Serum Biomarkers in Patients with Colorectal Cancer Anticancer Research, May 17, 2012    Clinical Article

7 Helicobacter pylori infection: what's new Current Opinion in Infectious Diseases, May 17, 2012

8 The Survivin Suppressant YM155 Potentiates Chemosensitivity to Gemcitabine in the Human Pancreatic Cancer Cell Line MiaPaCa-2 Anticancer Research, May 17, 2012    Clinical Article

9 Expression Levels of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, and Thymidine Phosphorylase in Patients with Colorectal Cancer Anticancer Research, May 17, 2012    Clinical Article

10 Mucosal healing in Crohns disease: A systematic review Inflammatory Bowel Disease, May 17, 2012    Evidence Based Medicine

11 Incidence of Peptic Ulcer Bleeding in the US Pediatric Population Journal of Pediatric Gastroenterology and Nutrition, May 17, 2012

12 Healthcare Utilization and Comorbidity Burden among Children and Young Adults in the United States with Systemic Lupus Erythematosus or Inflammatory Bowel Disease The Journal of Pediatrics, May 17, 2012

13 Antibiotics as First-line Therapy for Acute Appendicitis: Evidence for a Change in Clinical Practice World Journal of Surgery, May 17, 2012    Clinical Article

14 Which is the best MRI marker of malignancy for atypical cirrhotic nodules: Hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration Journal of Magnetic Resonance Imaging, May 17, 2012

15 Classification of Gastritis in First-degree Relatives of Patients with Gastric Cancer in a High Cancer-risk Area in Italy Anticancer Research, May 17, 2012

16 Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study Journal of Viral Hepatitis, May 17, 2012

17 Growth and metabolic control in patients with type 1 diabetes and celiac disease: a longitudinal observational case-control study Pediatric Diabetes, May 17, 2012

18 Decrease of CD44-positive Cells Correlates with Tumor Response to Chemotherapy in Patients with Gastrointestinal Cancer Anticancer Research, May 17, 2012

19 Molecular Testing in Colorectal Cancer: Diagnosis of Lynch Syndrome and Personalized Cancer Medicine American Journal of Clinical Pathology, May 17, 2012

20 Esophageal Endoscopic Dilations Journal of Pediatric Gastroenterology and Nutrition, May 17, 2012

1 Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate Helicobacter, April 6, 2012

2 Adalimumab in steroid-dependent Crohns disease patients: Prognostic factors for clinical benefit Inflammatory Bowel Disease, April 17, 2012

3 Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohns Disease Gastroenterology, February 29, 2012

4 Serrated Polyp Detection Rate During Screening Colonoscopy Colorectal Disease, March 14, 2012

5 High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures Alimentary Pharmacology and Therapeutics, March 12, 2012

6 Natalizumab for moderate to severe Crohns disease in clinical practice Inflammatory Bowel Disease, April 3, 2012

7 Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease Inflammatory Bowel Disease, April 23, 2012

8 Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals Gastroenterology, April 6, 2012

9 Randomized Comparison of Two Non-Bismuth-Containing Second-line Rescue Therapies for Helicobacter pylori Helicobacter, April 11, 2012

10 Natalizumab for moderate to severe Crohns disease in clinical practice Inflammatory Bowel Disease, April 18, 2012

11 Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains Helicobacter, April 13, 2012

12 Scheduled infliximab monotherapy to prevent recurrence of Crohns disease following ileocolic or ileal resection: A 3-year prospective randomized open trial Inflammatory Bowel Disease, April 20, 2012

13 Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease Inflammatory Bowel Disease, April 16, 2012

14 Assessment of Helicobacter pylori Eradication by Virgin Olive Oil Helicobacter, April 24, 2012

15 Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing Diseases of the Esophagus, April 27, 2012

16 Vaniprevir with peginterferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C - a randomized phase 2 study Hepatology, April 19, 2012

17 Systematic review: antibodies and anti-TNF- levels in inflammatory bowel disease Alimentary Pharmacology and Therapeutics, April 12, 2012

18 Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis Journal of Digestive Diseases, March 27, 2012    Evidence Based Medicine

19 Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial The Lancet Infectious Diseases, March 27, 2012

20 The Association Between Barretts Esophagus and Helicobacter pylori Infection: A Meta-Analysis Helicobacter, April 3, 2012